Keith Regnante
Director of Finance/CFO bei KEROS THERAPEUTICS, INC.
Vermögen: - $ am 31.03.2024
Profil
Keith C.
Regnante is currently the Chief Financial Officer at Keros Therapeutics, Inc. He previously worked as the Senior Director-Corporate Finance at Biogen, Inc. from 1999 to 2013, Head-Research & Development Finance at ARIAD Pharmaceuticals, Inc. from 2013 to 2014, Vice President-Finance at Shire Pharmaceuticals, Inc. from 2014 to 2016, and Chief Financial & Accounting Officer at Wave Life Sciences Ltd.
from 2016 to 2020.
He received his undergraduate degree from Tufts University and his MBA from MIT Sloan School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
KEROS THERAPEUTICS, INC.
-.--% | 13.02.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Keith Regnante
| Unternehmen | Position | Beginn |
|---|---|---|
| KEROS THERAPEUTICS, INC. | Director of Finance/CFO | 01.02.2020 |
Ehemalige bekannte Positionen von Keith Regnante
| Unternehmen | Position | Ende |
|---|---|---|
| WAVE LIFE SCIENCES LTD. | Director of Finance/CFO | 09.01.2020 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Corporate Officer/Principal | 01.08.2016 |
| ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.02.2014 |
| BIOGEN INC. | Public Communications Contact | 01.08.2013 |
Ausbildung von Keith Regnante
| Tufts University | Undergraduate Degree |
| MIT Sloan School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BIOGEN INC. | Health Technology |
| WAVE LIFE SCIENCES LTD. | Health Technology |
| KEROS THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
